Peter Kies
CFO at Inovio Pharmaceuticals, Inc. (INO)
Peter Kies has filed 19 insider reports with the SEC since February 2021, as CFO at Inovio Pharmaceuticals, Inc. (INO). Peter Kies made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2026, reports grant or award, shares withheld for taxes or exercise price and exercise or conversion of a derivative at Inovio Pharmaceuticals, Inc. (INO).
- Filings
- 19
- Companies
- 1
- Bought on market
- None
- Sold on market
- $423K
Companies where Peter Kies is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CFO | 42,854 | $423K | $1.69 | May 21, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 20, 2026INOCFO Kies Peter converted options into 8,700 shares and covered exercise/tax liability with 4,688 shares, increasing direct ownership by 10% to 42,854 units (for tax liability)Form 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 15, 2026INOCFO Kies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,571 shares, increasing direct ownership by 6% to 38,842 units (for tax liability)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 4, 2026INOSEC Form 4 filed by CFO Kies PeterForm 4Grant or award
- Feb 26, 2026INOCFO Kies Peter converted options into 15,644 shares and covered exercise/tax liability with 9,259 shares, increasing direct ownership by 21% to 36,642 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 20, 2025INOSEC Form 4 filed by CFO Kies PeterForm 4Grant or award
- May 15, 2025INOCFO Kies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,566 shares, increasing direct ownership by 8% to 30,257 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 27, 2025INOCFO Kies Peter converted options into 9,007 shares and covered exercise/tax liability with 5,322 shares, increasing direct ownership by 15% to 28,052 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 15, 2024INOKies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,562 shares, increasing direct ownership by 10% to 24,367 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 15, 2023INOSEC Form 4 filed by Kies PeterForm 4Grant or award
- Mar 11, 2023INOSEC Form 4: Kies Peter converted options into 59,737 shares and covered exercise/tax liability with 31,410 shares, increasing direct ownership by 14% to 236,999 units (withholding obligation)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 27, 2023INOSEC Form 4: Kies Peter converted options into 70,511 shares and covered exercise/tax liability with 41,123 shares, increasing direct ownership by 16% to 208,672 units (tax liability)Form 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 11, 2022INOSEC Form 4: Kies Peter converted options into 59,737 shares and covered exercise/tax liability with 31,410 shares, increasing direct ownership by 19% to 179,284 units (tax liability)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 8, 2022INOSEC Form 4: Kies Peter converted options into 21,466 shares and covered exercise/tax liability with 11,287 shares, increasing direct ownership by 7% to 150,957 units to cover withholding taxForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 26, 2022INOSEC Form 4: Kies Peter converted options into 22,545 shares and covered exercise/tax liability with 12,555 shares, increasing direct ownership by 8% to 140,778 units (for tax liability)Form 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 9, 2021-$338KINOSEC Form 4: KIES PETER sold $337,838 worth of Common Stock (33,750 units at $10.01) and exercised 13,750 units of Common Stock at a strike of $2.16, decreasing direct ownership by 13% to 130,788 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 21, 2021-$85.2KINOSEC Form 4: KIES PETER sold $85,200 worth of Common Stock (10,000 units at $8.52), decreasing direct ownership by 6% to 160,788 unitsForm 4Open-market sale10b5-1 plan
- Mar 11, 2021INOSEC Form 4: Peter Kies exercised 59,737 units of Common Stock at a strike of $0.00 and disposed of $332,004 worth of Common Stock (31,410 units at $10.57), increasing direct ownership by 20% to 170,788 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 8, 2021INOSEC Form 4: Peter Kies exercised 49,033 units of Common Stock at a strike of $0.00 and disposed of $234,511 worth of Common Stock (25,862 units at $9.07), increasing direct ownership by 19% to 142,461 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 26, 2021INOSEC Form 4 filed by Peter KiesForm 4Grant or award
Compare Peter Kies with
- Peter Kies vs Wendy L Yarno1 shared
- Peter Kies vs Jay Shepard1 shared
- Peter Kies vs Ann Calby Miller1 shared
- Peter Kies vs David B. Weiner1 shared
- Peter Kies vs Lota S. Zoth1 shared
- Peter Kies vs Roger D Dansey1 shared
Other insiders at the same companies
- Wendy L YarnoINO
- Jay ShepardINO
- Ann Calby MillerINO
- David B. WeinerINO
- Lota S. ZothINO
- Roger D DanseyINO
- Simon X BenitoINO
- Laurent HumeauINO
- Michael John SumnerINO
- Jacqueline Elizabeth SheaINO
Questions about Peter Kies
- What is Peter Kies's role at Inovio Pharmaceuticals, Inc.?
- Peter Kies reports to the SEC as CFO at Inovio Pharmaceuticals, Inc. (INO), according to the latest filing on May 21, 2026.
- How many shares does Peter Kies own?
- After the latest filing that states it, Peter Kies directly owned 42,854 shares of Inovio Pharmaceuticals, Inc. (INO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter Kies bought or sold stock recently?
- The most recent open-market sale was on June 9, 2021: sold 33,750 shares of Inovio Pharmaceuticals, Inc. (INO) for $338K at an average of $10.01.
- How do I get alerts when Peter Kies files?
- Follow Peter Kies on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Peter Kies (SEC CIK 0001259780). Totals count each trade once, skipping amendments whose original is on file, from Feb 27, 2021 on. View on SEC EDGAR